PCC Rokita SA (PCR) Fair Value & Analysis
Basic Materials · PL · Market cap 1.3B PLN
Fair value as of: Jul 12, 2026
From 24 valuation models · updated 29 days ago
Fair value updated Jul 12, 2026, revised from 51.59 PLN to 83.92 PLN (+62.7%) since Jun 24, 2026. Share price +3.1% over the past month.
A solid business, screening 27% undervalued on our models.
What matters now
- Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
- Our model range runs from 62.94 PLN (bear) to 104.91 PLN (bull), base 83.92 PLN. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 54/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
60‑month range 40.40 PLN – 103.62 PLN · fair‑value band 62.94 PLN – 104.91 PLN · the 66.00 PLN price screens below the 83.92 PLN fair value. Dashed = 300-day average. As of Jul 12, 2026.
Analysis
PCC Rokita SA (PCR) currently trades at 66.00 PLN, while our model-based Fair Value estimate is 83.92 PLN, implying the stock looks roughly 27.2% undervalued today. The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, PCC Rokita SA generated revenue of 1.8B PLN at a net margin of 3.4%. Revenue declined 12.0% year over year. It earns a return on equity of 4.5%. Net debt stands at 322M PLN. Fundamentals as of Jul 12, 2026
Our scenario range runs from 62.94 PLN (bear case) to 104.91 PLN (bull case); at 66.00 PLN, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 9% below its 52-week high and 14% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at 27%, PCR screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth DCF (58.80 PLN) versus Earnings-Based (25.93 PLN). Highest evidence: Growth DCF (80).
Notify me when PCR reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 51
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities.
Full company description
PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities. The Polyurethanes segment produces polyols, polyurethane systems, and prepolymers; and flexible foams, rigid foams, coatings, elastomers, adhesives, impregnations, and other products. The Chlorine Derivatives segment provides chlorine, sodium hydroxide, caustic soda, chlorobenzene, and hydrochloric acid. The Other Chemical Activities segment offers phosphorus-derivative and naphthalene-derivative products. The Energy segment produces and distributes electricity, thermal energy, demineralized water, and compressed air. The Other Operations segment is involved in the provision of maintenance services for technological equipment and installations; industrial waste management; hazardous goods transport services; management and administration services; environmental protection; asset management and security; construction and repairs of steel industrial equipment; and trades in chemical products, and other. It also provides transport and freight, and maintenance services; research of chemical substances; and designs, constructs, and assembles, as well as repairs industrial equipment, tanks, pipelines, and welded structure. The company sells its products under the Crossin, Ekoprodur, ROKOPOL, and ROKESTER brands. PCC Rokita SA was incorporated in 2002 and is headquartered in Brzeg Dolny, Poland. PCC Rokita SA is a subsidiary of PCC SE.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PCC Rokita SA reported revenue of 1.8B PLN in FY2025 versus 2.2B PLN in FY2021, a compound −4.9%/yr. Reported net income was 61.5M PLN in FY2025, compounding −38.0%/yr from FY2021.
of which total revenue +9.7 pp · buybacks/dilution −0.5 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch PCR: get an alert when its fair value changes →
Peer Group
Chemicals · 333 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| BASF SE BASN | 1,034 MXN | 532.13 MXN | -49% |
| Ningxia Baofeng Energy Group 600989 | ¥20.32 | ¥20.17 | -1% |
| Zhejiang Juhua Co 600160 | ¥42.85 | ¥23.35 | -46% |
| PT Barito Pacific Tbk, BRPT | 1,690 IDR | 1,628 IDR | -4% |
| LG Chem, Ltd 051910 | 260,500 KRW | 587,755 KRW | +126% |
| Formosa Chemicals & Fibre Corporation 1326 | 66.10 TWD | 6.79 TWD | -90% |
| PTT Global Chemical Public Company PTTGC | 35.50 THB | 18.21 THB | -49% |
| 542812 542812 | ₹4,369 | ₹791.05 | -82% |
| Indorama Ventures Public Company IVL | 24.50 THB | 17.95 THB | -27% |
| Navin Fluorine International Limited NAVINFLUOR | ₹8,650 | ₹2,146 | -75% |
Compare PCC Rokita SA with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is PCC Rokita SA (PCR) overvalued or undervalued?
What is the fair value of PCR?
What is the quality score of PCR?
What is the revenue of PCC Rokita SA (PCR)?
What is the net profit margin of PCR?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PCC Rokita SA and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.